… metastatic HR+, HER2-low, or HER2-ultra-low breast cancer.1,2 Previously … indications, which include patients with HER2+ breast cancer.2 “Endocrine therapy is typically … for patients with HER2-low or HER2-ultralow metastatic breast cancer following disease …

… breast tumor treatment.66,67 Therefore, nanoparticle-based combination therapies represent promising breast cancer … other cancers, breast tumors are often … HER2-positive primary breast cancer: a multicenter Phase II clinical trial (PerSeUS-BC04). Breast Cancer …

… receptor 2-negative (HER2–) breast cancer (BC). The findings … receptor-positive/HER2– breast cancer (LEADER). npj Breast Cancer. January 7, … women with advanced breast cancer (MONALEESA-2). … with HR+/​HER2- early breast cancer (NATALEE). ClinicalTrials …

… Hurst diagnosed an early-stage HER2-negative, estrogen-driven tumor … patients with early-stage breast cancer are candidates for breast- … chemotherapy. “We treat breast cancer one patient at a … evaluation and diagnosis of breast cancer—under the care of …

… metastatic hormone receptor–positive, HER2-negative breast cancer who have previously received … with metastatic HR positive, HER2-negative breast cancer,” Ken Takeshita, MD, … treated metastatic HR positive HER2 negative breast cancer. News release. Daiichi …

… of HR-positive, HER2-negative early breast cancer in September, Novartis’ … rapid launch” in early breast cancer, Novartis CEO Vas Narasimhan … market share in early breast cancer within three months of … showing in first-line breast cancer. “I do believe …

… epidermal growth factor receptor 2 (HER2)-negative breast cancer. The Trop-2-directed …

… [HR-positive/HER2-negative advanced breast cancer] whose disease had progressed … HR+/HER2− locally advanced or metastatic breast cancer who have progressed … fulvestrant for HR+ HER2- locally advanced or metastatic breast cancer. ClinicalTrials.gov. …

… endocrine-susceptible breast cancers, the … HER2+ breast cancer represents an estimated 10% of all breast cancer … HER2-positive metastatic breast cancer. Presented at: San Antonio Breast Cancer … HER2‒ metastatic breast cancer: phase 1b study. NPJ Breast Cancer …

… positive, PIK3CA-mutated breast cancer live longer,” said … positive breast cancer accounts for approximately 70% of breast cancer cases … HR-positive, HER2-negative breast cancer who often have … advanced or metastatic breast cancer in various combinations. …